COYA 302 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LD rhIL-2 and CTLA-4 Ig

Filter by location:

Phoenix, Arizona1 trial

Study of COYA 302 for the Treatment of ALS

Barrow Neurological Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.